课题基金 / 基金详情

CORE--AUTOMATED COMBINED IN SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY

CORE--AUTOMATED COMBINED IN SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY
核心--自动化原位杂交与免疫组化相结合
批准号:
6102767
负责人:
WILLIAM T BELLAMY
金额:
$13.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2000-03-31

项目摘要

项目成果

WILLIAM T BELLAMY的其他基金

相似基金

相关文献

中文摘要
翻译
核心组件C:自动组合原位杂交(ISH)和 免疫组织化学(IHC)实验室。 这个核心的目的是提供一个自动化的设施, 杂交和免疫组织化学,这将特别有助于 项目1和项目3的顺利完成。使用仪器 在亚利桑那大学开发的,核心领导人已经开发了一个 促进快速组合ISH和IHC的动力学模式自动化测定 测定。采用该方法,反应可以在1-3小时内进行, 时间框架(1)。双标记IHC和ISH是有益的:(a)在共- 定位与发病机制相关的相互作用分子;(B)在相关 RNA信息到蛋白质产物;(c)在证明独特的诊断 免疫结构特征;和(d)证明肿瘤的克隆性 细胞该核心将直接影响项目1(具体目标#1),其中 α 3和α 6整联蛋白表达的重要性的问题 将被审查。它也将有助于目标2,其中层粘连蛋白5的作用 半桥粒形成的影响。核心C将支持项目 2在具体目标1和2中,其中β 4和α 6 t 将测试对侵袭的转染。核心C将支持项目3, 提供蛋白质和mRNA定位以研究表达 基质溶解素在皮下和原位LNCaP肿瘤中的模式 免疫缺陷小鼠
英文摘要
CORE COMPONENT C: Automated combined in situ hybridization (ISH) and immunohistochemistry (IHC) laboratory. The purpose of this core is to provide a facility for automated in situ hybridization and immunohistochemistry which will specifically assist in the successful completion of Projects 1 and 3. Using instrumentation developed at the University of Arizona, the Core Leaders have developed a kinetic-mode automated assay which facilitates rapid combined ISH and IHC assays. With this procedure, reactions can be performed within a 1-3 hour time frame (1). Double labeling IHC and ISH are of benefit: (a) in co- localizing interactive molecules relevant to pathogenesis; (b) in relating RNA message to protein product; (c) in demonstrating unique diagnostic immunoarchitectural features; and (d) in demonstrating clonality of tumor cells. This core will directly impact Project 1 (Specific Aim #1) wherein the question of the importance of alpha3 and alpha6 integrin expression will be examined. It will also aid in Aim 2 where the effect of laminin 5 on hemidesmosome formation will be examined. Core C will support Project 2 in Specific Aims 1 and 2 in which the effect of beta 4 and alpha 6t transfection on invasion will be tested. Core C will support Project 3 by providing both protein and mRNA localization to study the expression pattern of matrilysin in subcutaneous and orthotopic LNCaP tumors in immunodeficient mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Experimental Cellular Pathology
  • 批准号:
    7725632
  • 项目类别:
  • 资助金额:
    $14.06万
  • 财政年份:
    2009
  • 负责人:
    WILLIAM T BELLAMY
  • 依托单位:
Core--IMMUNODEFICIENT MOUSE COLONY
  • 批准号:
    6990133
  • 项目类别:
  • 资助金额:
    $5.84万
  • 财政年份:
    2004
  • 负责人:
    WILLIAM T BELLAMY
  • 依托单位:
CORE--AUTOMATED COMBINED IN SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY
  • 批准号:
    6435837
  • 项目类别:
  • 资助金额:
    $19.72万
  • 财政年份:
    2001
  • 负责人:
    WILLIAM T BELLAMY
  • 依托单位:
CORE--AUTOMATED COMBINED IN SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY
  • 批准号:
    6300439
  • 项目类别:
  • 资助金额:
    $13.98万
  • 财政年份:
    2000
  • 负责人:
    WILLIAM T BELLAMY
  • 依托单位:
海外基金